ICM
TTPH

ISZO Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

ISZO Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-600
Closed -$90K – 16
2015
Q3 		$90K Buy
+600
New +$440K 0.05% 11

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

ISZO Capital Management's TTPH Position: Q4 2015 in Review

ISZO Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 600 shares — an estimated $90K sold.

ISZO Capital Management first reported a position in TTPH in Q3 2015 and held it in 1 quarter. The position peaked at $90K in Q3 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • ISZO Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • ISZO Capital Management sold 600 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $90K.
  • ISZO Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • ISZO Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $90K in Q3 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on ISZO Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.